rs79713097

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001161352.2(KCNMA1):​c.945C>T​(p.Ala315Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00274 in 1,613,564 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 16 hom. )

Consequence

KCNMA1
NM_001161352.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.652

Publications

4 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Illumina
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.131).
BP6
Variant 10-77112382-G-A is Benign according to our data. Variant chr10-77112382-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 300969.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.652 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00294 (448/152302) while in subpopulation NFE AF = 0.00348 (237/68034). AF 95% confidence interval is 0.00312. There are 2 homozygotes in GnomAd4. There are 246 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001161352.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNMA1
NM_001161352.2
MANE Select
c.945C>Tp.Ala315Ala
synonymous
Exon 7 of 28NP_001154824.1Q12791-1
KCNMA1
NM_001437422.1
c.1077C>Tp.Ala359Ala
synonymous
Exon 8 of 28NP_001424351.1
KCNMA1
NM_001161353.2
c.945C>Tp.Ala315Ala
synonymous
Exon 7 of 28NP_001154825.1Q12791-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNMA1
ENST00000286628.14
TSL:1 MANE Select
c.945C>Tp.Ala315Ala
synonymous
Exon 7 of 28ENSP00000286628.8Q12791-1
KCNMA1
ENST00000626620.3
TSL:1
c.945C>Tp.Ala315Ala
synonymous
Exon 7 of 28ENSP00000485867.1Q12791-2
KCNMA1
ENST00000639406.1
TSL:1
c.945C>Tp.Ala315Ala
synonymous
Exon 7 of 29ENSP00000491732.1B7ZMF5

Frequencies

GnomAD3 genomes
AF:
0.00294
AC:
448
AN:
152184
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0161
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00348
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.00337
AC:
848
AN:
251382
AF XY:
0.00318
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00685
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0165
Gnomad NFE exome
AF:
0.00346
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00272
AC:
3975
AN:
1461262
Hom.:
16
Cov.:
30
AF XY:
0.00260
AC XY:
1890
AN XY:
726974
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33458
American (AMR)
AF:
0.000313
AC:
14
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00628
AC:
164
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86236
European-Finnish (FIN)
AF:
0.0151
AC:
806
AN:
53404
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00253
AC:
2814
AN:
1111488
Other (OTH)
AF:
0.00275
AC:
166
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
193
385
578
770
963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00294
AC:
448
AN:
152302
Hom.:
2
Cov.:
32
AF XY:
0.00330
AC XY:
246
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41558
American (AMR)
AF:
0.000327
AC:
5
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.0161
AC:
171
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00348
AC:
237
AN:
68034
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00276
Hom.:
1
Bravo
AF:
0.00168
EpiCase
AF:
0.00322
EpiControl
AF:
0.00290

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Generalized epilepsy-paroxysmal dyskinesia syndrome (2)
-
-
1
KCNMA1-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
5.2
DANN
Benign
0.86
PhyloP100
0.65
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79713097; hg19: chr10-78872140; COSMIC: COSV54237041; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.